Literature DB >> 26688151

Percutaneous left atrial appendage closure for stroke prevention in India: The beginning of a new era.

Adel Aminian1, Georges Khalil2, Apostolos Tzikas3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26688151      PMCID： PMC4688432          DOI： 10.1016/j.ihj.2015.07.023

Source DB:  PubMed          Journal:  Indian Heart J        ISSN： 0019-4832


× No keyword cloud information.
  10 in total

1.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial.

Authors:  Vivek Y Reddy; Horst Sievert; Jonathan Halperin; Shephal K Doshi; Maurice Buchbinder; Petr Neuzil; Kenneth Huber; Brian Whisenant; Saibal Kar; Vijay Swarup; Nicole Gordon; David Holmes
Journal:  JAMA       Date:  2014-11-19       Impact factor: 56.272

2.  Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population.

Authors:  Susan Colilla; Ann Crow; William Petkun; Daniel E Singer; Teresa Simon; Xianchen Liu
Journal:  Am J Cardiol       Date:  2013-07-04       Impact factor: 2.778

3.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

4.  Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug.

Authors:  Apostolos Tzikas; Samera Shakir; Sameer Gafoor; Heyder Omran; Sergio Berti; Gennaro Santoro; Joelle Kefer; Ulf Landmesser; Jens Erik Nielsen-Kudsk; Ignacio Cruz-Gonzalez; Horst Sievert; Tobias Tichelbäcker; Prapa Kanagaratnam; Fabian Nietlispach; Adel Aminian; Friederike Kasch; Xavier Freixa; Paolo Danna; Marco Rezzaghi; Paul Vermeersch; Friederike Stock; Miroslava Stolcova; Marco Costa; Reda Ibrahim; Wolfgang Schillinger; Bernhard Meier; Jai-Wun Park
Journal:  EuroIntervention       Date:  2016-02       Impact factor: 6.534

5.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.

Authors:  David R Holmes; Saibal Kar; Matthew J Price; Brian Whisenant; Horst Sievert; Shephal K Doshi; Kenneth Huber; Vivek Y Reddy
Journal:  J Am Coll Cardiol       Date:  2014-07-08       Impact factor: 24.094

6.  Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Arch Intern Med       Date:  1987-09

7.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

8.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial.

Authors:  David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Maurice Buchbinder; Christopher M Mullin; Peter Sick
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

9.  Economic evaluation of percutaneous left atrial appendage occlusion, dabigatran, and warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.

Authors:  Sheldon M Singh; Andrew Micieli; Harindra C Wijeysundera
Journal:  Circulation       Date:  2013-05-22       Impact factor: 29.690

Review 10.  Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure.

Authors:  Rajiv Mahajan; Anthony G Brooks; Thomas Sullivan; Han S Lim; Muayad Alasady; Hany S Abed; Anand N Ganesan; Sachin Nayyar; Dennis H Lau; Kurt C Roberts-Thomson; Jonathan M Kalman; Prashanthan Sanders
Journal:  Heart       Date:  2012-05-09       Impact factor: 5.994
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.